I go to my investment group and say let's buy a stake in the shares (despite the quarter, SSRX is the market share leader) -- that, either company can do regardless of CHinese govt hurdles. Anyone know if SSRX has any poison pills in place?
I would think this is a short term disappointment. Call me crazy, but I am somehow still optimistic this will do well in the long term.
100% agree, which is why I would think IR with a competiting company, &/or a venture capital group would jump at it now.It went from over $17 post stellar quarter in Nov. down to $11.70 yesterday. Now I wonder whether it'll do the opposite (and go up) with this setback quarter.